Page 81 - MemoriaESP-Eng

www.ciberesp.es

• g-b D, r-V e, r r, c r. Spatio-temporal analysis of tu-
Most relevant óMezArrosooDríguezAlínAMisAno
berculosis in Spain, 2008-2010.Int J Tuberc Lung Dis. 2013 Jun;17(6):745-51.
scientific
• JiMénez-Jorge s, De MAteo s, DelgADo-sAnz c, pozo F, cAsAs i, gArcíA-cenoz M. Effective-
articles
ness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-
2012 season in Spain, among population targeted for vaccination.BMC Infect Dis.

2013 Sep 22;13:441.

• FernánDez-DáVilA p, FolcH c, Ferrer l, soriAno r, Diez M, cAsAbonA J. Who are the men
who have sex with men in Spain that have never been tested for HIV?HIV Med. 2013

Oct;14 Suppl 3:44-8.

• Kissling e, VAlenciAno M, lArrAuri A, oroszi b, coHen JM, nunes b et Al.. Low and decrea-
sing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination

target groups in Europe: results from the I-MOVE multicentre case-control study.
Euro Surveill. 2013 Jan 31;18(5).

• H c, M VA, g p, l cM, n g, p t ..
ADJicHristoDoulououcHtouriuglielMettieMosicHolsAuxet Al
Actions for prevention and control of health threats related to maritime transport in

European Union.Travel Med Infect Dis. 2013 Jul-Aug;11(4):238-42.

Highlights
During 2013 our group is involved in 12 research projects in different competi-
tive research calls at national and international level. Two of these projects are

financed by the Ministry of Health” “Prevalence of HIV/Chlamydia trachomatis
co-infection among clients of STI clinics” and ”Risk behaviors for HIV infection in

clients of sexually transmitted infections and HIV clinics”. The international pro-

ject“ “SHIPSAN ACT, studies the impact on maritime transport of health threats
due to biological, chemical and radiological agents, including communicable disea-

ses” the associated member from Spain belongs to the group 32. In the field of

immunopreventable diseases the project “cycEVA: Case control study measuring
A(H1N1) 2009 pandemic and seasonal influenza vaccine effectiveness in Spain

within the project several European countries uses common European protocols,
with the European network I-MOVE, to evaluate the influenza vaccine effective-

ness seasonal or pandemic epidemic.

The Knowledge transfer products were “Revision of pertussis vaccination program

in Spain”. The study updates the situation of the pertussis vaccination program
in Spain and the available evidence for the impact of the different vaccinations

strategies on the epidemiology of pertussis. Other Knowledge transfer product

was“ “Report on the estimates of influenza vaccine effectiveness in the 2012/13
seasons”, a review of the scientific evidence of influenza vaccine effectiveness

2012-13, to support the WHO Selection Committee in the selection of the influen-
za strain to be included in the influenza vaccine of the following season. The report

includes the results from 16 international studies of influenza vaccine effective-
13
ness both in the north and south hemisphere.
20
T
OR
P
RE
L
A
NU
N
A
P /
S
RE
E
IB
C

81